Document Detail


Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure.
MedLine Citation:
PMID:  7350803     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
To study the effect of prazosin therapy on left ventricular function in patients with chronic stable heart failure, first pass radionuclide angiography at rest and during exercise was performed in 15 patients before the administration of prazosin and after seven to 12 weeks of prazosin therapy. There was no significant change in resting ejection fraction before and during prazosin therapy (36 +/- 14 per cent versus 37 +/- 14 per cent) (mean +/- standard deviation). However, exercise ejection fraction increased from 34 +/- 14 per cent to 42 +/- 17 per cent (p less than 0.01). The difference in ejection fraction from rest to exercise (ejection fraction response) changed significantly from -2 +/- 6 per cent before prazosin therapy to +5 +/- 7 per cent during prazosin therapy (p less than 0.01). Exercise duration increased from 368 +/- 82 seconds to 476 +/- 82 seconds (p less than 0.01). Total work capacity measured in kilojoules increased from 12.6 +/- 8.3 to 18.6 +/- 10.4 (p less than 0.01). The improved ejection fraction response during prazosin therapy correlated with the improved work capacity (r = 0.69, p less than 0.01) and exercise duration (p = 0.59, p less than 0.05). This improvement occurred despite a significant weight gain with prazosin from 72.2 +/- 20.8 kg to 73.5 +/- 20.8 kg (p less than 0.01). These data suggest that long-term prazosin therapy is effective in the treatment of heart failure. However, the beneficial effects of prazosin, an alpha 1 blocking agent, may be evident only during exercise.
Authors:
S A Goldman; L L Johnson; E Escala; P J Cannon; M B Weiss
Related Documents :
2319793 - Evaluation of postoperative flow capacity of internal mammary artery.
3374173 - Prognostic value and limitations of exercise radionuclide angiography in medically trea...
14578373 - Cardiovascular and respiratory responses to apneas with and without face immersion in e...
Publication Detail:
Type:  Journal Article; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The American journal of medicine     Volume:  68     ISSN:  0002-9343     ISO Abbreviation:  Am. J. Med.     Publication Date:  1980 Jan 
Date Detail:
Created Date:  1980-02-28     Completed Date:  1980-02-28     Revised Date:  2008-11-21    
Medline Journal Info:
Nlm Unique ID:  0267200     Medline TA:  Am J Med     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  36-42     Citation Subset:  AIM; IM; S    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Blood Pressure
Cardiac Output
Female
Heart Failure / drug therapy*,  physiopathology,  radionuclide imaging
Heart Rate
Humans
Male
Middle Aged
Myocardial Contraction
Physical Exertion*
Prazosin / therapeutic use*
Quinazolines / therapeutic use*
Chemical
Reg. No./Substance:
0/Quinazolines; 19216-56-9/Prazosin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The effect of training on strength and endurance of the diaphragm in quadriplegia.
Next Document:  Renal failure after major angiography.